Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes

Published:2014-02-27 Issue:11 Volume:120 Page:1670-1676
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Steensma David P.¹,Komrokji Rami S.²,Stone Richard M.¹,List Alan F.²,Garcia-Manero Guillermo³,Huber John M.⁴,Dennison Betsy⁵,Sekeres Mikkael A.⁶

Affiliation:

1. Division of Hematological Malignancies, Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

2. Department of Medical Oncology, H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

3. Department of Leukemia, The University of Texas MD Anderson Cancer Center; Houston Texas

4. Aplastic Anemia & Myelodysplastic Syndromes International Foundation; Rockville Maryland

5. Clarity Communications; Pompton Lakes New Jersey

6. Department of Hematologic Oncology and Blood Disorders; Cleveland Clinic Taussig Cancer Institute; Cleveland Ohio

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28631/fullpdf

Reference23 articles.

1. The myelodysplastic syndromes: diagnosis and treatment;Steensma;Mayo Clin Proc.,2006

2. Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need;Goldberg;Transfusion.,2012

3. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey;Steensma;Leuk Res.,2008

4. Myelodysplastic syndromes: incidence and survival in the United States;Ma;Cancer.,2007

5. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries;Cogle;Blood.,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada;Current Oncology;2023-08-30

3. Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2022-09

5. Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome;Patient Related Outcome Measures;2022-02